Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance and an increased risk of cardiovascular and liver damage. It is diagnosed through identification of risk factors including obesity, diabetes, and hyperlipidemia. The disease is linked to mechanisms like insulin resistance affecting lipid metabolism and inflammatory pathways, which can also impact the risk of heart disease and vascular damage over time.
2. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary
heart disease
Abstract
Non-alcoholic fatty liver disease is marked by hepatic fat accumulation not due to alcohol abuse. Several studies have demonstrated that
NAFLD is associated with insulin resistance leading to a resistance in the antilipolytic effect of insulin in the adipose tissue with an increase of
free fatty acids (FFAs). The increase of FFAs induces mitochondrial dysfunction and development of lipotoxicity. Moreover, in subjects with
NAFLD, ectopic fat also accumulates as cardiac and pancreatic fat. In this review we analyzed the mechanisms that relate NAFLD with
metabolic syndrome and dyslipidemia and its association with the development and progression of cardiovascular disease.
____________________________
We are medical librarians conducting an experiment to understand the global visibility of non-English medical research articles. The
translation for this abstract was performed by a certified translator. The PubMed citation and link to the whole open access article can be
found here https://www.ncbi.nlm.nih.gov/pubmed/?term=23666091. Please feel free to add your comments below on the project and, if you are
a native-speaker, on the quality of the translation.
--Lilian Hoffecker and Dana Abbey, Health Sciences Library, University of Colorado.